This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Robert's Most Recent Article

Are Fund Managers Better Than Their Funds?

04/20/09 - 04:51 PM EDT

For investors still cringing at their IRAs, 401(k)s or taxable mutual funds and exchange-traded funds, are you ready to take a chance on the companies that have brought you so many unhappy returns?

read more >

Other Articles by Robert

Free Reports

After Exubera, Uncertainty Reigns

10/22/07 - 04:01 PM EDT

Pfizer's decision to drop inhaled insulin could dim the prospects for competing products.

read more >
Hot Art From the Arctic

10/19/07 - 09:47 AM EDT

Inuit prints from northern Canada offer a beautiful -- and affordable -- investment.

read more >
Can Good Health Last for Medical IPOs?

09/11/07 - 02:20 PM EDT

The first part of the year was solid for new biotechs and health stocks.

read more >
Challenges Persist for Glaxo

08/22/07 - 04:43 PM EDT

Fans say the company is too big to fail, but it's also too big to grow much without developing more hits.

read more >
J&J's Risperdal Gets New Uses

08/22/07 - 04:35 PM EDT

The drug is approved by the FDA for younger patients.

read more >
Pfizer Finds New CFO

08/22/07 - 11:18 AM EDT

Frank D'Amelio will join the company from Alcatel-Lucent.

read more >
FDA Approves Novartis Osteoporosis Drug

08/20/07 - 05:19 PM EDT

Reclast is a once-a-year treatment.

read more >
Glaxo Drug Gets Black Box

08/14/07 - 05:38 PM EDT

Avandia will carry a new warning.

read more >
Wyeth Whacked on Drug Setbacks

08/10/07 - 01:49 PM EDT

It gets bad news from the FDA and pulls a hepatitis C drug candidate.

read more >
One Giant Leap for MannKind

08/09/07 - 05:48 PM EDT

The company will sell $350 million in debt, warrants and stock.

read more >
Page 3 of 147
Top Rated Stocks Top Rated Funds Top Rated ETFs